glp-1 vision loss ema recommendation november 2025 Wegovy Lawsuit [2026 Update] EU actions to tackle shortages

Meta-analyses suggest that 620mg daily can slightly raise HDL (good) cholesterol and lower triglycerides and systolic blood pressure, though effects remain small overall.28 29 30 31 Who are they not for

La FDA lo excluy de compounding en 2022

Exendin 939, a synthetic peptide derived from exendin-4 via N-terminal truncation and sharing 53% sequence homology with GLP-1, functions as a specific and competitive antagonist of GLP-1R [27]

Common adverse effects across these medications include nausea, vomiting, diarrhea, and constipation, along with more serious risks such as thyroid C-cell tumors (in animal studies), pancreatitis, and gallbladder disease